0
New
New
2023
Medical Gases Market

Medical Gases Market

by Product (Pure medical gases, Medical gases mixture), by Application (Therapeutics, Diagnostics, Others), by End User (Hospitals, Pharmaceutical and biotechnology companies, Diagnostic centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A00407
Jul 2023 | Pages: 270
Tables: 130
Charts: 69
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Medical Gases Market Research, 2032

The global medical gases market size was valued at $8.5 billion in 2022, and is projected to reach $16.7 billion by 2032, growing at a CAGR of 7% from 2023 to 2032. Medical gases find a wide range of usage in the medical and pharmaceutical industry. Healthcare providers use these gases for diagnosis and treatment of patients with various diseases. Examples of medical gases that are used in healthcare settings include hydrogen, oxygen, hydrogen, nitrous oxide, nitrogen, and carbon dioxide. These gases are produced, packaged, and delivered to patients under anesthesia, in therapy, or for diagnosis through medical gas equipment. 

“The COVID-19 pandemic had a positive impact on the medical gases market as it increased the importance of oxygen gas for COVID-19 treatment. In addition, the increased awareness about respiratory diseases during the pandemic led to a surge in demand for medical gases both for diagnosis and treatment procedures, contributing toward the market growth.”

Medical Gases Market

Market Dynamics  

The medical gases market size is experiencing significant growth due to various driving factors including the increase in prevalence of respiratory diseases, rise in surgical procedures and surge in awareness of home healthcare. Respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma and respiratory infection, are on the rise around the globe. Medical gases such as oxygen, helium or nitrous oxide are used for treatment such as therapy with oxygen, nebulizers and inhalations. Thus, there is a surge in demand for medical gases in hospitals and at home healthcare settings with a rise in prevalence of respiratory diseases. This propels the growth of the medical gases market share. 

In addition, various applications of medical gases in the healthcare sector are fostering market growth. For instance, dry ice is formed from carbon dioxide by applying a pressure of 5.2 atmospheres and cooling to a temperature of -56.6°C. This dry ice finds application in the treatment of cataracts and other vascular diseases. On the other hand, oxygen is provided to individuals with oxygen deficiency and small amounts of nitrous oxide may act as an analgesic and anesthetic agent. Such applications of medical gases in diagnosis and treatment propel the medical gases market growth. 

Furthermore, the rise in number of surgeries contribute to the growth of medical gases market share. Medical gases may be used in many types of surgical procedures including anesthesia, respiratory support, and other purposes. Thus, there is a growing need for medical gases in the healthcare sector, with rise in the number of surgical procedures and ageing population. 

However, strict regulations on the production and supply of medical gases act as a restraint for the growth of the market. The regulation of medical gases is highly stringent, and the manufacturers and healthcare providers need to follow set guidelines to manufacture and market their product. Compliance with the regulations is time-consuming and expensive, and non-compliance can lead to significant penalties. This is projected to hinder market growth to some extent. 

For instance, in November 2022, the World Health Organization (WHO) published ‘WHO good manufacturing practices for medicinal gases’, that provides guidelines, which focus on the production, control, storage and distribution of medicinal gases. Thus, the stringent regulations regarding manufacturing of medical gases may be a significant restraint for the medical gases market. 

However, developing regions with advanced healthcare facilities and cost advantages attract medical tourists from other countries. Medical gases are an integral part of healthcare services provided to these international patients for surgeries, diagnostics, and post-operative care. This is further anticipated to foster market growth during the medical gases market forecast period. 

The COVID-19 pandemic had a significant impact on medical gas usage and supply. COVID-19 is primarily a respiratory illness, and in severe cases, patients may experience low oxygen levels. This led to an increased demand for medical oxygen in hospitals and other healthcare facilities. With the pandemic, there has been an increased demand for medical gases from non-traditional markets, such as field hospitals and other temporary medical facilities. This has led to changes in distribution channels and new partnerships between manufacturers and distributors. 

The increased demand for medical oxygen has led to shortages in some areas, particularly in low- and middle-income countries. This has been a significant challenge for healthcare providers who are treating COVID-19 patients. However, post pandemic initiatives are taken by the key players and government to normalize the medical gases supply which is anticipated to drive the market growth during the forecast period. 

Segmental Overview 

The global medical gases market is segmented on the basis of product, application, end user and region. On the basis of the product, the market is bifurcated into pure medical gases and medical gases mixture. The pure gases segment is further categorized into oxygen, carbon dioxide, nitrogen, nitrous oxide and others. Whereas the medical gas mixture segment is further divided into medical air and others. On the basis of application, the market is categorized into therapeutics, diagnostics and others. By end user, the market is classified into hospitals, pharmaceutical and biotechnology companies, diagnostic centers and others. 

By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).  

By Product 

Depending on product, the pure medical gases segment dominated the medical gases market in 2022 in terms of revenue. This growth is mainly attributed to the surge in demand for pure medical gases, especially oxygen, in the diagnosis and treatment of various diseases. In addition, surge in investments by the key players and the government support for the manufacturing of oxygen gas is driving the growth of the segment. 

For instance, in October 2021, Indian Prime Minister Shri Narendra Modi announced to dedicate 35 PSA Oxygen Plants across 35 States and Union Territories, as a proactive measures to address oxygen shortage. Such initiatives taken up by the government and key players are anticipated to contribute to market growth.  

On the other hand, the medical gases mixture segment is anticipated to grow at the fastest rate during the forecast period. The surge in demand for medical gases mixture for calibration of medical instruments, and its application in diagnosis of various diseases is expected to drive the market growth during the forecast period. In addition, key players are offering a wide range of medical gases mixtures having wide applications in the healthcare sector, which is further expected to drive the market growth. 

Medical Gases Market

By Application 

On the basis of application, the therapeutics segment dominated the market in terms of revenue in 2022 owing to the surge in demand for medical gases which are administered to patients for the treatment of various medical conditions or to support vital bodily functions. For instance, oxygen therapy is used for anemia, a condition in which the body has a decreased number of red blood cells, leading to a reduced oxygen-carrying capacity. Such applications of medical gases in treatment of various conditions increases its demand and thus fosters the segment growth. 

Medical Gases Market

By End User  

Based on end user, the hospitals segment dominated the market terms of revenue in 2022 owing to the rise in demand for medical gases from the hospitals. Rise in the number of hospitalizations owing to the ise in number of patients suffering from respiratory disease act as one of the major factors driving the growth of the medical gases industry. 

On the other hand, the others segment is expected to experience the fastest growth rate during the forecast period. This growth is mainly attributed to the rise in geriatric population and the subsequent surge in demand for home healthcare. Many of these patients prefer to receive medical care and treatment in the comfort of their homes rather than in hospitals or medical facilities. This contributes to the demand for medical gases in home healthcare and drives the growth of others segment.

Medical Gases Market

By Region 

The market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the medical gases market in 2022 in terms of revenue. The growth is mainly attributed to the availability of advanced healthcare infrastructure in this region. As the hospitals and other healthcare facilities offer advanced facilities it also includes the use of instruments and procedures requiring medical gases for operations. This contributes to the demand for medical gases in this region. 

On the contrary, the Asia-Pacific region is anticipated to grow at a fastest CAGR during the forecast period. This growth is attributed to the large patient pool in this region and high population base in countries such as India and China. Furthermore, the developing countries in Asia-Pacific such as China, Japan, and India serve as the potential markets for medical gases, as these countries are witnessing rise in heart and respiratory diseases. 

In addition, oxygen is the most essential medical gas, and there is a significant investment by the government for establishing oxygen plants in this region. This is anticipated to boost the revenue generation from the Asia-Pacific region.  

Medical Gases Market

Competition Analysis

Competition analysis and profiles of the major players in the medical gases industry, such as Air Products and Chemicals, Inc., DCC Plc, Linde plc, Messer Holding GmbH, SOL Spa, Nippon Sanso Holdings Corporation, Air Liquide, PT Samator Indo Gas Tbk, NOL Group and WestAir Gases and Equipment Inc. are provided in this report.  

There are some important players in the market such as Catalina Cylinders, Tri-TechMedical Inc., American Welding & Gas, Chengdu Taiyu Industrial Gases Co., Ltd., MVS Engineering Pvt. Ltd., INOX-Air Products Inc., Chemtron Science Laboratories Private Limited. and others. Major players have adopted acquisition as key developmental strategies to improve the product portfolio of medical gases.   

Recent Acquisition in the Medical Gases Market 

In July 2020, Air Liquide announced the acquisition of Sasol's 16 Air Separation Units (ASU) located in Secunda, South Africa. Air Liquide will operate the biggest oxygen production site in the world with a plan to reduce its CO2 emissions by 30% to 40% within the next ten years. 

Recent Agreement in the Medical Gases Market 

In November 2021, Nippon Sanso Holdings Corporation (NSHD), announced the execution of a raw gas supply agreement with Enlink Midstream, LLC and will also be constructing a state-of-the-art facility in Texas dedicated to the production of liquefied carbon dioxide and dry ice. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical gases market analysis from 2022 to 2032 to identify the prevailing medical gases market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the market segmentation assists to determine the prevailing medical gases market opportunity.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical gases market trends, key players, market segments, application areas, and market growth strategies.

Medical Gases Market Report Highlights

Aspects Details
Market Size By 2032 USD 16.7 billion
Growth Rate CAGR of 7%
Forecast period 2022 - 2032
Report Pages 270
By Product
  • Pure medical gases
    • Type
      • Oxygen
      • Carbon dioxide
      • Nitrous oxide
      • Nitrogen
      • Others
  • Medical gases mixture
    • Type
      • Medical air
      • Others
By Application
  • Therapeutics
  • Diagnostics
  • Others
By End User
  • Hospitals
  • Pharmaceutical and biotechnology companies
  • Diagnostic centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Air Liquide, Nippon Sanso Holdings Corporation, NOL Group, Air Products and Chemicals, Inc., DCC Plc, PT Samator Indo Gas Tbk., WestAir Gases And Equipment Inc., SOL Spa, Linde plc, Messer Holding GmbH
Taiyo Nippon Sanso Corp, Messer Group, Matheson Tri-Gas, H.A.C Technical Gas Services, Cranney Companies, RS Gases, Sharjah Oxygen Company, Ellenbarrie industrial Gases, MEC Medical Ltd.

Analyst Review

The medical gases market presents several opportunities and challenges. The medical gases market has witnessed notable growth owing to a rise in prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), and asthma, which further increases the demand for medical gases. 

In addition, the expanding global population, particularly the aging demographics, contributes to the demand for medical gases as the susceptibility geriatric patients are more prone to chronic disorders. Moreover, surge in demand for oxygen therapies as a lifesaving treatment in various conditions is further boosting the market growth. In addition, improved healthcare infrastructure, especially in developing regions, enhances access to diagnosis and treatment, contributing to the growing demand for medical gases.  

Furthermore, in North America, several driving factors contribute to the growth of the medical gases market. Increase in cases of cardiac diseases and respiratory diseases, rise in surgical procedures, availability of robust healthcare infrastructure, and strong presence of key players are contributing to the market growth. On the other hand, Asia-Pacific is anticipated to witness notable growth during the forecast period owing to rise in investments by the key players in production and development of medical gases to fulfill the local needs of oxygen, large population base, and surge in access to healthcare services.  

 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Low bargaining power of suppliers

      • 3.3.2. Moderate threat of new entrants

      • 3.3.3. Low threat of substitutes

      • 3.3.4. Low intensity of rivalry

      • 3.3.5. Low bargaining power of buyers

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Increase in prevalence of respiratory diseases
        • 3.4.1.2. Rise in number of surgical procedures
        • 3.4.1.3. Rise in adoption of Home Healthcare

      • 3.4.2. Restraints

        • 3.4.2.1. Stringent regulations for manufacturing and supply of medical gas

      • 3.4.3. Opportunities

        • 3.4.3.1. Growth opportunities in developing regions

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: MEDICAL GASES MARKET, BY PRODUCT

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Pure medical gases

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

      • 4.2.4. Pure medical gases Medical Gases Market by Type

    • 4.3. Medical gases mixture

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

      • 4.3.4. Medical gases mixture Medical Gases Market by Type

  • CHAPTER 5: MEDICAL GASES MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Therapeutics

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Diagnostics

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Others

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

  • CHAPTER 6: MEDICAL GASES MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Pharmaceutical and biotechnology companies

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Diagnostic centers

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

    • 6.5. Others

      • 6.5.1. Key market trends, growth factors and opportunities

      • 6.5.2. Market size and forecast, by region

      • 6.5.3. Market share analysis by country

  • CHAPTER 7: MEDICAL GASES MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Product

      • 7.2.3. Market size and forecast, by Application

      • 7.2.4. Market size and forecast, by End User

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Product
          • 7.2.5.1.3. Market size and forecast, by Application
          • 7.2.5.1.4. Market size and forecast, by End User
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Product
          • 7.2.5.2.3. Market size and forecast, by Application
          • 7.2.5.2.4. Market size and forecast, by End User
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Product
          • 7.2.5.3.3. Market size and forecast, by Application
          • 7.2.5.3.4. Market size and forecast, by End User
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Product

      • 7.3.3. Market size and forecast, by Application

      • 7.3.4. Market size and forecast, by End User

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Product
          • 7.3.5.1.3. Market size and forecast, by Application
          • 7.3.5.1.4. Market size and forecast, by End User
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Product
          • 7.3.5.2.3. Market size and forecast, by Application
          • 7.3.5.2.4. Market size and forecast, by End User
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Product
          • 7.3.5.3.3. Market size and forecast, by Application
          • 7.3.5.3.4. Market size and forecast, by End User
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Product
          • 7.3.5.4.3. Market size and forecast, by Application
          • 7.3.5.4.4. Market size and forecast, by End User
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Product
          • 7.3.5.5.3. Market size and forecast, by Application
          • 7.3.5.5.4. Market size and forecast, by End User
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Product
          • 7.3.5.6.3. Market size and forecast, by Application
          • 7.3.5.6.4. Market size and forecast, by End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Product

      • 7.4.3. Market size and forecast, by Application

      • 7.4.4. Market size and forecast, by End User

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Product
          • 7.4.5.1.3. Market size and forecast, by Application
          • 7.4.5.1.4. Market size and forecast, by End User
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Product
          • 7.4.5.2.3. Market size and forecast, by Application
          • 7.4.5.2.4. Market size and forecast, by End User
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Product
          • 7.4.5.3.3. Market size and forecast, by Application
          • 7.4.5.3.4. Market size and forecast, by End User
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Product
          • 7.4.5.4.3. Market size and forecast, by Application
          • 7.4.5.4.4. Market size and forecast, by End User
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Product
          • 7.4.5.5.3. Market size and forecast, by Application
          • 7.4.5.5.4. Market size and forecast, by End User
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Product
          • 7.4.5.6.3. Market size and forecast, by Application
          • 7.4.5.6.4. Market size and forecast, by End User
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Product

      • 7.5.3. Market size and forecast, by Application

      • 7.5.4. Market size and forecast, by End User

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Product
          • 7.5.5.1.3. Market size and forecast, by Application
          • 7.5.5.1.4. Market size and forecast, by End User
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Product
          • 7.5.5.2.3. Market size and forecast, by Application
          • 7.5.5.2.4. Market size and forecast, by End User
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Product
          • 7.5.5.3.3. Market size and forecast, by Application
          • 7.5.5.3.4. Market size and forecast, by End User
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Product
          • 7.5.5.4.3. Market size and forecast, by Application
          • 7.5.5.4.4. Market size and forecast, by End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Nippon Sanso Holdings Corporation

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

      • 9.1.6. Business performance

      • 9.1.7. Key strategic moves and developments

    • 9.2. Air Products and Chemicals, Inc.

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

      • 9.2.6. Business performance

    • 9.3. DCC Plc

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. Linde plc

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Messer Holding GmbH

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

      • 9.5.6. Business performance

    • 9.6. PT Samator Indo Gas Tbk.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

    • 9.7. NOL Group

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

      • 9.7.6. Business performance

    • 9.8. SOL Spa

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

      • 9.8.7. Key strategic moves and developments

    • 9.9. Air Liquide

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

      • 9.9.6. Business performance

    • 9.10. WestAir Gases And Equipment Inc.

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

  • LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 02. MEDICAL GASES MARKET FOR PURE MEDICAL GASES, BY REGION, 2022-2032 ($MILLION)
    TABLE 03. GLOBAL PURE MEDICAL GASES MEDICAL GASES MARKET, BY TYPE, 2022-2032 ($MILLION)
    TABLE 04. MEDICAL GASES MARKET FOR MEDICAL GASES MIXTURE, BY REGION, 2022-2032 ($MILLION)
    TABLE 05. GLOBAL MEDICAL GASES MIXTURE MEDICAL GASES MARKET, BY TYPE, 2022-2032 ($MILLION)
    TABLE 06. GLOBAL MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 07. MEDICAL GASES MARKET FOR THERAPEUTICS, BY REGION, 2022-2032 ($MILLION)
    TABLE 08. MEDICAL GASES MARKET FOR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
    TABLE 09. MEDICAL GASES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
    TABLE 10. GLOBAL MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 11. MEDICAL GASES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
    TABLE 12. MEDICAL GASES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
    TABLE 13. MEDICAL GASES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2022-2032 ($MILLION)
    TABLE 14. MEDICAL GASES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
    TABLE 15. MEDICAL GASES MARKET, BY REGION, 2022-2032 ($MILLION)
    TABLE 16. NORTH AMERICA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 17. NORTH AMERICA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 18. NORTH AMERICA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 19. NORTH AMERICA MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 20. U.S. MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 21. U.S. MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 22. U.S. MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 23. CANADA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 24. CANADA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 25. CANADA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 26. MEXICO MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 27. MEXICO MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 28. MEXICO MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 29. EUROPE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 30. EUROPE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 31. EUROPE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 32. EUROPE MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 33. GERMANY MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 34. GERMANY MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 35. GERMANY MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 36. FRANCE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 37. FRANCE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 38. FRANCE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 39. UK MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 40. UK MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 41. UK MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 42. ITALY MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 43. ITALY MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 44. ITALY MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 45. SPAIN MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 46. SPAIN MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 47. SPAIN MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 48. REST OF EUROPE MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 49. REST OF EUROPE MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 50. REST OF EUROPE MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 51. ASIA-PACIFIC MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 52. ASIA-PACIFIC MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 53. ASIA-PACIFIC MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 54. ASIA-PACIFIC MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 55. JAPAN MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 56. JAPAN MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 57. JAPAN MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 58. CHINA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 59. CHINA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 60. CHINA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 61. INDIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 62. INDIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 63. INDIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 64. AUSTRALIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 65. AUSTRALIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 66. AUSTRALIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 67. SOUTH KOREA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 68. SOUTH KOREA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 69. SOUTH KOREA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 70. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 71. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 72. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 73. LAMEA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 74. LAMEA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 75. LAMEA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 76. LAMEA MEDICAL GASES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
    TABLE 77. BRAZIL MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 78. BRAZIL MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 79. BRAZIL MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 80. SAUDI ARABIA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 81. SAUDI ARABIA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 82. SAUDI ARABIA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 83. SOUTH AFRICA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 84. SOUTH AFRICA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 85. SOUTH AFRICA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 86. REST OF LAMEA MEDICAL GASES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
    TABLE 87. REST OF LAMEA MEDICAL GASES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
    TABLE 88. REST OF LAMEA MEDICAL GASES MARKET, BY END USER, 2022-2032 ($MILLION)
    TABLE 89. NIPPON SANSO HOLDINGS CORPORATION: KEY EXECUTIVES
    TABLE 90. NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT
    TABLE 91. NIPPON SANSO HOLDINGS CORPORATION: PRODUCT SEGMENTS
    TABLE 92. NIPPON SANSO HOLDINGS CORPORATION: PRODUCT PORTFOLIO
    TABLE 93. NIPPON SANSO HOLDINGS CORPORATION: KEY STRATERGIES
    TABLE 94. AIR PRODUCTS AND CHEMICALS, INC.: KEY EXECUTIVES
    TABLE 95. AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT
    TABLE 96. AIR PRODUCTS AND CHEMICALS, INC.: PRODUCT SEGMENTS
    TABLE 97. AIR PRODUCTS AND CHEMICALS, INC.: PRODUCT PORTFOLIO
    TABLE 98. DCC PLC: KEY EXECUTIVES
    TABLE 99. DCC PLC: COMPANY SNAPSHOT
    TABLE 100. DCC PLC: PRODUCT SEGMENTS
    TABLE 101. DCC PLC: PRODUCT PORTFOLIO
    TABLE 102. LINDE PLC: KEY EXECUTIVES
    TABLE 103. LINDE PLC: COMPANY SNAPSHOT
    TABLE 104. LINDE PLC: PRODUCT SEGMENTS
    TABLE 105. LINDE PLC: PRODUCT PORTFOLIO
    TABLE 106. MESSER HOLDING GMBH: KEY EXECUTIVES
    TABLE 107. MESSER HOLDING GMBH: COMPANY SNAPSHOT
    TABLE 108. MESSER HOLDING GMBH: PRODUCT SEGMENTS
    TABLE 109. MESSER HOLDING GMBH: PRODUCT PORTFOLIO
    TABLE 110. PT SAMATOR INDO GAS TBK.: KEY EXECUTIVES
    TABLE 111. PT SAMATOR INDO GAS TBK.: COMPANY SNAPSHOT
    TABLE 112. PT SAMATOR INDO GAS TBK.: PRODUCT SEGMENTS
    TABLE 113. PT SAMATOR INDO GAS TBK.: PRODUCT PORTFOLIO
    TABLE 114. NOL GROUP: KEY EXECUTIVES
    TABLE 115. NOL GROUP: COMPANY SNAPSHOT
    TABLE 116. NOL GROUP: PRODUCT SEGMENTS
    TABLE 117. NOL GROUP: PRODUCT PORTFOLIO
    TABLE 118. SOL SPA: KEY EXECUTIVES
    TABLE 119. SOL SPA: COMPANY SNAPSHOT
    TABLE 120. SOL SPA: PRODUCT SEGMENTS
    TABLE 121. SOL SPA: PRODUCT PORTFOLIO
    TABLE 122. SOL SPA: KEY STRATERGIES
    TABLE 123. AIR LIQUIDE: KEY EXECUTIVES
    TABLE 124. AIR LIQUIDE: COMPANY SNAPSHOT
    TABLE 125. AIR LIQUIDE: PRODUCT SEGMENTS
    TABLE 126. AIR LIQUIDE: PRODUCT PORTFOLIO
    TABLE 127. WESTAIR GASES AND EQUIPMENT INC.: KEY EXECUTIVES
    TABLE 128. WESTAIR GASES AND EQUIPMENT INC.: COMPANY SNAPSHOT
    TABLE 129. WESTAIR GASES AND EQUIPMENT INC.: PRODUCT SEGMENTS
    TABLE 130. WESTAIR GASES AND EQUIPMENT INC.: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 01. MEDICAL GASES MARKET, 2022-2032
    FIGURE 02. SEGMENTATION OF MEDICAL GASES MARKET, 2022-2032
    FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL GASES MARKET (2023-2032)
    FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
    FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
    FIGURE 06. LOW THREAT OF SUBSTITUTES
    FIGURE 07. LOW INTENSITY OF RIVALRY
    FIGURE 08. LOW BARGAINING POWER OF BUYERS
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL GASES MARKET
    FIGURE 09. MEDICAL GASES MARKET, BY PRODUCT, 2022(%)
    FIGURE 10. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR PURE MEDICAL GASES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR MEDICAL GASES MIXTURE, BY COUNTRY 2022 AND 2032(%)
    FIGURE 12. MEDICAL GASES MARKET, BY APPLICATION, 2022(%)
    FIGURE 13. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR THERAPEUTICS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 16. MEDICAL GASES MARKET, BY END USER, 2022(%)
    FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL GASES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
    FIGURE 21. MEDICAL GASES MARKET BY REGION, 2022
    FIGURE 22. U.S. MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 23. CANADA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 24. MEXICO MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 25. GERMANY MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 26. FRANCE MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 27. UK MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 28. ITALY MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 29. SPAIN MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 30. REST OF EUROPE MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 31. JAPAN MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 32. CHINA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 33. INDIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 34. AUSTRALIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 35. SOUTH KOREA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 36. REST OF ASIA-PACIFIC MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 37. BRAZIL MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 38. SAUDI ARABIA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 39. SOUTH AFRICA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 40. REST OF LAMEA MEDICAL GASES MARKET, 2022-2032 ($MILLION)
    FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 45. COMPETITIVE DASHBOARD
    FIGURE 46. COMPETITIVE HEATMAP: MEDICAL GASES MARKET
    FIGURE 47. TOP PLAYER POSITIONING, 2022
    FIGURE 48. NIPPON SANSO HOLDINGS CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 49. NIPPON SANSO HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 50. AIR PRODUCTS AND CHEMICALS, INC.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 51. AIR PRODUCTS AND CHEMICALS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 52. AIR PRODUCTS AND CHEMICALS, INC.: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 53. DCC PLC: NET REVENUE, 2021-2023 ($MILLION)
    FIGURE 54. DCC PLC: REVENUE SHARE BY SEGMENT, 2023 (%)
    FIGURE 55. DCC PLC: REVENUE SHARE BY REGION, 2023 (%)
    FIGURE 56. LINDE PLC: NET SALES, 2020-2022 ($MILLION)
    FIGURE 57. LINDE PLC: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
    FIGURE 58. LINDE PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 59. LINDE PLC: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 60. MESSER HOLDING GMBH: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 61. MESSER HOLDING GMBH: REVENUE SHARE BY REGION, 2022 (%)
    FIGURE 62. PT SAMATOR INDO GAS TBK.: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 63. PT SAMATOR INDO GAS TBK.: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 64. NOL GROUP: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 65. SOL SPA: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 66. SOL SPA: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 67. AIR LIQUIDE: NET REVENUE, 2020-2022 ($MILLION)
    FIGURE 68. AIR LIQUIDE: REVENUE SHARE BY SEGMENT, 2022 (%)
    FIGURE 69. AIR LIQUIDE: REVENUE SHARE BY REGION, 2022 (%)

 
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The forecast period for medical gases market is 2023 to 2032.

A. The base year is 2022 in medical gases market.

A. Major players that operate in the medical gases market are Air Products and Chemicals, Inc., DCC Plc, Linde plc, Messer Holding GmbH, SOL Spa, Nippon Sanso Holdings Corporation, Air Liquide, Samator Group, NOL Group and WestAir Gases and Equipment Inc.

A. Key factors driving the growth of the medical gases market includes increase in prevalence of respiratory diseases, rise in number of surgical procedures and rise in adoption of home healthcare.

A. Asia-Pacific has the highest growth rate in the market with 7.8% CAGR owing to to rise in investments by the key players in production and development of medical gases to fulfill the local needs of oxygen, large population base, and surge in access to healthcare services.

A. The pure medical gases segment is the most influencing segment in the market owing to the surge in demand for these medical gases in the treatment of various diseases.

A. The total market value of medical gases market is $8.5 billion in 2022.

A. The market value of medical gases market in 2032 is $16.7 billion.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Medical Gases Market

Start reading instantly.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jul 2024 - Jul 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2024 - Jul 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2024 - Jul 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2024 - Jul 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jul 2024 - Jul 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers